India has initiated an anti-dumping investigation into imports of ethyl chloroformate from China, following concerns raised by domestic manufacturers over alleged unfair pricing practices.
The probe, launched by the Directorate General of Trade Remedies, aims to determine whether the chemical is being exported to India at prices below normal value, potentially harming the local industry.
Ethyl chloroformate is a key intermediate used in pharmaceuticals, agrochemicals, and specialty chemical production. Domestic producers have argued that a surge in low-priced imports has adversely impacted their margins, capacity utilisation, and overall competitiveness.
As part of the investigation, authorities will examine import volumes, pricing trends, and the extent of injury, if any, to Indian manufacturers. If dumping is established and found to be causing material harm, the government may impose anti-dumping duties to ensure a level playing field.
Industry experts note that such measures are critical to protecting domestic industries from unfair trade practices while maintaining a balanced approach to imports required for downstream sectors.
The investigation is expected to follow standard timelines, with opportunities for all stakeholders—including exporters, importers, and domestic producers—to present their views before a final determination is made.
The move underscores India’s continued use of trade remedy mechanisms to safeguard local industries amid evolving global trade dynamics.
